Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study

BACKGROUND: World Health Organization (WHO) grade IV glioma remains one of the most lethal tumors with a dismal prognosis and inevitable recurrence. We evaluated the safety and efficacy of immunotherapy with radiotherapy in this population of patients. METHODS: This study was a single-arm, open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Haihui, Yu, Kefu, Cui, Yong, Ren, Xiaohui, Li, Mingxiao, Yang, Chuanwei, Zhao, Xuzhe, Zhu, Qinghui, Lin, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138184/
https://www.ncbi.nlm.nih.gov/pubmed/34025640
http://dx.doi.org/10.3389/fimmu.2021.632547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138184/
https://www.ncbi.nlm.nih.gov/pubmed/34025640
http://dx.doi.org/10.3389/fimmu.2021.632547

Ejemplares similares